[2014-Dec-19] FDA approves Viekira Pak to treat hepatitis C

[2014-Dec-19] FDA approves Viekira Pak to treat hepatitis C

http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm427530.htm

Viekira Pak.cdx

David A. DeGoey, John T. Randolph, Dachun Liu, John Pratt, Charles Hutchins, Pamela Donner, A. Chris Krueger, Mark Matulenko, Sachin Patel, Christopher E. Motter, Lissa Nelson, Ryan Keddy, Michael Tufano, Daniel D. Caspi, Preethi Krishnan, Neeta Mistry, Gennadiy Koev, Thomas J. Reisch, Rubina Mondal, Tami Pilot-Matias, Yi Gao, David W. A. Beno, Clarence J. Maring, Akhter Molla, Emily Dumas, Andrew Campbell, Laura Williams, Christine Collins, Rolf Wagner, and Warren M. Kati, Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A, J. Med. Chem., 2014, 57 (5), pp 2047–2057

http://dx.doi.org/10.1021/jm401398x

V. A. Eagling,

D. J. Back and

M. G. Barry, 

Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir, Br. J. Clin. Pharmacol., 1997, 44 (2), pp 190-194

http://dx.doi.org/10.1046%2Fj.1365-2125.1997.00644.x

http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206619lbl.pdf